QualityStocks would like to highlight Eternity Healthcare (
OTCQB: ETAH), leading the way in the development and marketing of medical devices. The company is a leader in the discovery, developing, and marketing of medical devices, currently focused on their Comfort-in needle-free injection system. Their products are sold to healthcare professionals for use in physicians’ offices, pharmacies, and all consumers.
In the company’s news,
Eternity Healthcare announced it is developing a noninvasive sugar monitoring device for diabetics that uses saliva instead of blood. The technology employs an ultra-sensitive sugar monitor and an added sensor for salivary amylase enzyme activity.
Eternity Healthcare is the first company to focus on developing an alternative saliva-based glucose monitoring test. The device will utilize two parameters of diabetes physiological changes to provide diabetics with blood sugar level results that are more accurate. It is anticipated that the test will reduce patients’ reliance on the current method of finger pricking and blood collection.
The major providers of glucose monitoring devices are big pharmaceutical companies such as Abbott Diabetic Care, Inc.; Bayer Healthcare; AG LifeScan, Inc.; Roche Diagnostics Corp.; Medtronic, Inc.; DexCom, Inc. and others. More than 10 million glucose monitor devices and several hundred-million test strips are sold each year, according the Centers for Disease Control. Worldwide, the market for blood glucose monitoring devices was $8.9 billion in 2010, and that market is expected to grow to $16 billion this year.
A biopharmaceutical company, Eternity Healthcare has technologies in diagnostics and medical devices. The company is currently focused on products that target diabetic needs, including a needle-free injection device. The company’s products are sold to healthcare professionals, pharmacies, and directly to consumers. Eternity Healthcare currently has numerous additional diagnostic tests and medical devices in development for metabolic, cardiovascular, and neurodegenerative diseases and cancer.
About QualityStocks
QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts and connecting subscribers with companies that have huge potential to succeed in the short and long-term future.
To sign up for The QualityStocks Daily Newsletter, please visit
www.QualityStocks.net
To connect with QualityStocks via Facebook, please visit http://Facebook.com/QualityStocksPage
To connect with QualityStocks via Twitter, please visit http://Twitter.com/QualityStocks
Please read FULL disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.net
Forward-Looking Statement:
This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.
